National Health Investors (NYSE:NHI) is scheduled to be releasing its earnings data after the market closes on Monday, February 22nd. Analysts expect National Health Investors to post earnings of $1.36 per share for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.
NYSE NHI opened at $70.08 on Monday. The business has a 50-day moving average price of $67.55 and a 200-day moving average price of $64.17. National Health Investors has a twelve month low of $31.37 and a twelve month high of $91.12. The firm has a market cap of $3.13 billion, a price-to-earnings ratio of 16.45 and a beta of 0.88. The company has a quick ratio of 13.13, a current ratio of 13.13 and a debt-to-equity ratio of 1.02.
The company also recently declared a quarterly dividend, which was paid on Friday, January 29th. Investors of record on Thursday, December 31st were paid a dividend of $1.102 per share. This represents a $4.41 dividend on an annualized basis and a yield of 6.29%. The ex-dividend date of this dividend was Wednesday, December 30th. National Health Investors’s payout ratio is presently 80.18%.
In other National Health Investors news, Director Robert G. Adams purchased 2,000 shares of National Health Investors stock in a transaction dated Monday, December 14th. The shares were purchased at an average cost of $67.75 per share, for a total transaction of $135,500.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Robert G. Adams purchased 1,000 shares of National Health Investors stock in a transaction dated Tuesday, November 17th. The stock was acquired at an average price of $66.45 per share, for a total transaction of $66,450.00. The disclosure for this purchase can be found here. Corporate insiders own 5.74% of the company’s stock.
He picked Apple back in 2003… BEFORE shares skyrocketed almost 48,000%.
He picked Bitcoin when it was trading for just $428. Since then, it has exploded by over 9,000%.
A number of equities analysts recently commented on the company. BMO Capital Markets lowered National Health Investors from a “market perform” rating to an “underperform” rating and set a $68.00 price target for the company. in a research note on Thursday, January 7th. Zacks Investment Research lowered National Health Investors from a “buy” rating to a “hold” rating in a research note on Thursday, January 14th. Berenberg Bank lowered National Health Investors from a “buy” rating to a “hold” rating in a research note on Wednesday, December 2nd. Mizuho lowered National Health Investors from a “neutral” rating to an “underperform” rating and lowered their price objective for the company from $56.00 to $55.00 in a research note on Wednesday, January 13th. Finally, KeyCorp raised National Health Investors from an “underweight” rating to a “sector weight” rating in a research note on Monday, December 14th. Two equities research analysts have rated the stock with a sell rating and seven have assigned a hold rating to the company. National Health Investors currently has an average rating of “Hold” and a consensus price target of $61.57.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI’s portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Featured Story: What is a recession?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Historically low-interest rates have made it difficult over the last decade for income-oriented investors that want to generate safe cash flow for their retirements.
Dividend-paying stocks have become more appealing to income investors because of their competitive yields, the favorite tax treatment that dividends receive, and their ability to grow their payouts over time. While fixed interest rates from bond investments will lose purchasing power to inflation over time, the purchasing power of income from dividend growth stocks is more protected because companies tend to raise their dividend payments every year.
In this slideshow, we look at ten of the best high-dividend stocks that offer strong yields (above 3.5%), have consistent cash flow, and a strong track record of dividend growth. The companies in this slideshow have all raised their dividend every year for the last ten years.
These companies also have low payout ratios (below 75%), meaning that they will have the ability to continue to pay their dividend if their earnings have a temporary dip.
Stock prices will always fluctuate, but the dividends paid by these rock-solid dividend payers should remain secure with moderate earnings growth.